Related references
Note: Only part of the references are listed.PredischaRge initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial
Robert J. Mentz et al.
AMERICAN HEART JOURNAL (2020)
Heart Failure With Reduced Ejection Fraction A Review
Sean P. Murphy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The Chang Gung Research Database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan
Shih-Chieh Shao et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)
Safety and efficacy of off-label use of ivabradine in patients with acute heart failure
Khaled M. Said Othman et al.
JOURNAL OF THE SAUDI HEART ASSOCIATION (2019)
Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction
Nasrien E. Ibrahim et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2019)
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
Karen A. Hicks et al.
CIRCULATION (2018)
Optimization of heart rate lowering therapy in hospitalized patients with heart failure: Insights from the Optimize Heart Failure Care Program
Yuri M. Lopatin et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study
Chun-Li Wang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Effect of Early Treatment With Ivabradine Plus Beta-blockers on Long-term Outcomes in Patients Hospitalized With Systolic Heart Failure
Francisco Hidalgo et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2018)
Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial
Takeshi Kitai et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure
Dipak Kotecha et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Chang Gung Research Database: A multi-institutional database consisting of original medical records
Ming-Shao Tsai et al.
BIOMEDICAL JOURNAL (2017)
Ivabradine in Heart Failure The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure
Debraj Das et al.
CIRCULATION-HEART FAILURE (2017)
Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis
Bart A. Mulder et al.
CLINICAL CARDIOLOGY (2017)
Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and Costs
Adam D. DeVore et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Clinical Experience with Ivabradine in Acute Heart Failure
Marina Pascual Izco et al.
CARDIOLOGY (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Effect of early treatment with ivabradine combined with beta-blockers versus beta- blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study
Francisco J. Hidalgo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Atrial Fibrillation After Coronary Artery Bypass Surgery: Can Ivabradine Reduce Its Occurrence?
Zainab Abdel-Salam et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2016)
Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis
Joanne Simpson et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Acute Decompensated Heart Failure Update
John R. Teerlink et al.
CURRENT CARDIOLOGY REVIEWS (2015)
The prognostic significance of atrial fibrillation in heart failure with a preserved and reduced left ventricular function: insights from a meta-analysis
Min Cheng et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Hemodynamic effects of Ivabradine in addition to dobutamine in patients with severe systolic dysfunction
Romain Gallet et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation
Anh L. Bui et al.
AMERICAN HEART JOURNAL (2013)
New Therapeutic Targets in Cardiology Heart Failure and Arrhythmia: HCN Channels
Francois Roubille et al.
CIRCULATION (2013)
Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study
P. G. Steg et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2013)
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg et al.
LANCET (2010)
Meta-analysis: beta-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
Finlay A. McAlister et al.
ANNALS OF INTERNAL MEDICINE (2009)
Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure
Andreas Link et al.
CLINICAL RESEARCH IN CARDIOLOGY (2009)
Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure
Gaetano M. De Ferrari et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Atrial fibrillation in heart failure patients: Prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry
Gaetano M. De Ferrari et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Impact of atrial fibrillation on mortality in patients with chronic heart failure
MP van den Berg et al.
EUROPEAN JOURNAL OF HEART FAILURE (2002)
Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men
MA Hernan et al.
EPIDEMIOLOGY (2000)